Benzodiazepines should still be first-line treatment for alcohol withdrawal

Gro Askgaard; Anton Pottegård; Anders Fink-Jensen

Benzodiazepines should still be first-line treatment for alcohol withdrawal

Gro Askgaard, Anton Pottegård, Anders Fink-Jensen

3 Citationer (Scopus)

Abstract

In this review, we summarize the evidence for benzodiazepines and barbiturates as alcohol withdrawal treatment and outline a treatment guideline. A number of randomized controlled trials (RCTs) indicate that benzodiazepine treatment decreases alcohol withdrawal seizures and is safe. For barbiturates, only a few RCTs have been undertaken, and barbiturates were not found to be superior to benzodiazepines. Consequently, we suggest that benzodiazepines should still be first-line treatment for alcohol withdrawal.

Bidragets oversatte titel	Benzodiazepines should still be first-line treatment for alcohol withdrawal
Originalsprog	Dansk
Tidsskrift	Ugeskrift for Laeger
Vol/bind	179
Udgave nummer	3
Sider (fra-til)	V07160465
ISSN	0041-5782
Status	Udgivet - 16 jan. 2017

Andre filer og links

Link to publication in Scopus

Citationsformater

@article{c27abed78c8a4269b9ed10446bfed663,

title = "Benzodiazepines should still be first-line treatment for alcohol withdrawal",

abstract = "In this review, we summarize the evidence for benzodiazepines and barbiturates as alcohol withdrawal treatment and outline a treatment guideline. A number of randomized controlled trials (RCTs) indicate that benzodiazepine treatment decreases alcohol withdrawal seizures and is safe. For barbiturates, only a few RCTs have been undertaken, and barbiturates were not found to be superior to benzodiazepines. Consequently, we suggest that benzodiazepines should still be first-line treatment for alcohol withdrawal.",

keywords = "English Abstract, Journal Article",

author = "Gro Askgaard and Anton Potteg{\aa}rd and Anders Fink-Jensen",

year = "2017",

month = jan,

day = "16",

language = "Dansk",

volume = "179",

pages = "V07160465",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "3",

}

TY - JOUR

T1 - Benzodiazepines should still be first-line treatment for alcohol withdrawal

AU - Askgaard, Gro

AU - Pottegård, Anton

AU - Fink-Jensen, Anders

PY - 2017/1/16

Y1 - 2017/1/16

N2 - In this review, we summarize the evidence for benzodiazepines and barbiturates as alcohol withdrawal treatment and outline a treatment guideline. A number of randomized controlled trials (RCTs) indicate that benzodiazepine treatment decreases alcohol withdrawal seizures and is safe. For barbiturates, only a few RCTs have been undertaken, and barbiturates were not found to be superior to benzodiazepines. Consequently, we suggest that benzodiazepines should still be first-line treatment for alcohol withdrawal.

AB - In this review, we summarize the evidence for benzodiazepines and barbiturates as alcohol withdrawal treatment and outline a treatment guideline. A number of randomized controlled trials (RCTs) indicate that benzodiazepine treatment decreases alcohol withdrawal seizures and is safe. For barbiturates, only a few RCTs have been undertaken, and barbiturates were not found to be superior to benzodiazepines. Consequently, we suggest that benzodiazepines should still be first-line treatment for alcohol withdrawal.

KW - English Abstract

KW - Journal Article

UR - https://www.scopus.com/pages/publications/85060303209

M3 - Tidsskriftartikel

C2 - 28115043

SN - 0041-5782

VL - 179

SP - V07160465

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 3

ER -

Benzodiazepines should still be first-line treatment for alcohol withdrawal

Abstract

Andre filer og links

Fingeraftryk

Citationsformater